Adenovirus-mediated delivery of human IFNγ gene inhibits prostate cancer growth

Life Sciences

Volumn 81, Issue 9, 2007, Pages 695-701

  Zhao, Peng ^a   Zhu, Ying Hui ^a   Wu, Jiang Xue ^a   Liu, Ran Yi ^a   Zhu, Xiu Yun ^a   Xiao, Xia ^a   Li, Hong Li ^a   Huang, Bi Jun ^a   Xie, Fa Jun ^a   Chen, Jie Min ^a   Ke, Miao La ^a   Huang, Wenlin ^a,b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

Adenoviral vector; Gene therapy; IFN ; Prostate cancer

Indexed keywords

ADENOVIRUS VECTOR; RECOMBINANT GAMMA INTERFERON;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG SAFETY; EMBRYO; GENE TRANSFER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERFERON PRODUCTION; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENE; TREATMENT OUTCOME; TUMOR XENOGRAFT; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION;

ADENOVIRIDAE; ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; INTERFERON TYPE II; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PROSTATIC NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

ADENOVIRIDAE;

EID: 34548013282     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.05.028     Document Type: Article

References (28)

1. Ahmed C.M., Burkhart M.A., Subramaniam P.S., Mujtaba M.G., and Johnson H.M. Peptide mimetics of gamma interferon possess antiviral properties against vaccinia virus and other viruses in the presence of poxvirus B8R protein. Journal of Virology 79 9 (2005) 5632-5639
2. Boehm U., Klamp T., Groot M., and Howard J.C. Cellular responses to interferon-gamma. Annual Review of Immunology 15 (1997) 749-795
3. Carnaud C., Lee D., Donnars O., Park S.H., Beavis A., Koezuka Y., and Bendelac A. Cutting edge: cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. Journal of Immunology 163 9 (1999) 4647-4650
4. Curnis F., Gasparri A., Sacchi A., Cattaneo A., Magni F., and Corti A. Targeted delivery of IFNgamma to tumor vessels uncouples antitumor from counterregulatory mechanisms. Cancer Research 65 7 (2005) 2906-2913
5. Denmeade S.R., and Isaacs J.T. A history of prostate cancer treatment. Nature Reviews Cancer 2 5 (2002) 389-396
6. Detjen K.M., Farwig K., Welzel M., Wiedenmann B., and Rosewicz S. Interferon gamma inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis. Gut 49 2 (2001) 251-262
7. Dummer R., Hassel J.C., Fellenberg F., Eichmuller S., Maier T., Slos P., Acres B., Bleuzen P., Bataille V., Squiban P., Burg G., and Urosevic M. Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas. Blood 104 6 (2004) 1631-1638
8. Dunn G.P., Sheehan K.C., Old L.J., and Schreiber R.D. IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression. Cancer Research 65 8 (2005) 3447-3453
9. Fathallah-Shaykh H.M., Zhao L.J., Kafrouni A.I., Smith G.M., and Forman J. Gene transfer of IFN-gamma into established brain tumors represses growth by antiangiogenesis. Journal of Immunology 164 1 (2000) 217-222
10. Gattacceca F., Pilatte Y., Billard C., Monnet I., Moritz S., Le Carrou J., Eloit M., and Jaurand M.C. Ad-IFN gamma induces antiproliferative and antitumoral responses in malignant mesothelioma. Clinical Cancer Research 8 10 (2002) 3298-3304
11. He G.A., Xue G., Xiao L., Wu J.X., Xu B.L., Huang J.L., Liang Z.H., Xiao X., Huang B.J., Liu R.Y., and Huang W. Dynamic distribution and expression in vivo of human endostatin gene delivered by adenoviral vector. Life Sciences 77 12 (2005) 1331-1340
12. Hoglund P., Sundback J., Olsson-Alheim M.Y., Johansson M., Salcedo M., Ohlen C., Ljunggren H.G., Sentman C.L., and Karre K. Host MHC class I gene control of NK-cell specificity in the mouse. Immunological Reviews 155 (1997) 11-28
13. Ikehara S., Pahwa R.N., Fernandes G., Hansen C.T., and Good R.A. Functional T cells in athymic nude mice. Proceedings of the National Academy of Sciences of the United States of America 81 3 (1984) 886-888
14. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., and Thun M.J. Cancer statistics, 2006. CA: a Cancer Journal for Clinicians 56 2 (2006) 106-130
15. Johansson S., Johansson M., Rosmaraki E., Vahlne G., Mehr R., Salmon-Divon M., Lemonnier F., Karre K., and Hoglund P. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. The Journal of Experimental Medicine 201 7 (2005) 1145-1155
16. Kominsky S., Johnson H.M., Bryan G., Tanabe T., Hobeika A.C., Subramaniam P.S., and Torres B. IFNgamma inhibition of cell growth in glioblastomas correlates with increased levels of the cyclin dependent kinase inhibitor p21WAF1/CIP1. Oncogene 17 23 (1998) 2973-2979
17. Kominsky S.L., Hobeika A.C., Lake F.A., Torres B.A., and Johnson H.M. Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells. Cancer Research 60 14 (2000) 3904-3908
18. Nielsen L.L. NK cells mediate the anti-tumor effects of E1-deleted, type 5 adenovirus in a human tumor xenograft model. Oncology Reports 7 1 (2000) 151-155
19. Pienta K.J., and Smith D.C. Advances in prostate cancer chemotherapy: a new era begins. CA: a Cancer Journal for Clinicians 55 5 (2005) 300-318
20. Propper D.J., Chao D., Braybrooke J.P., Bahl P., Thavasu P., Balkwill F., Turley H., Dobbs N., Gatter K., Talbot D.C., Harris A.L., and Ganesan T.S. Low-dose IFN-gamma induces tumor MHC expression in metastatic malignant melanoma. Clinical Cancer Research 9 1 (2003) 84-92
21. Raikwar S.P., Temm C.J., Raikwar N.S., Kao C., Molitoris B.A., and Gardner T.A. Adenoviral vectors expressing human endostatin-angiostatin and soluble Tie2: enhanced suppression of tumor growth and antiangiogenic effects in a prostate tumor model. Molecular Therapy 12 6 (2005) 1091-1100
22. Sarkar D., Su Z.Z., Vozhilla N., Park E.S., Randolph A., Valerie K., and Fisher P.S. Targeted virus replication plus immunotherapy eradicates primary and distant pancreatic tumors in nude mice. Cancer Research 65 19 (2005) 9056-9063
23. Sasagawa T., Hlaing M., and Akaike T. Synergistic induction of apoptosis in murine hepatoma Hepa1-6 cells by IFN-gamma and TNF-alpha. Biochemical and Biophysical Research Communications 272 3 (2000) 674-680
24. Selleck W.A., Canfield S.E., Hassen W.A., Meseck M., Kuzmin A.I., Eisensmith R.C., Chen S.H., and Hall S.J. IFN-gamma sensitization of prostate cancer cells to Fas-mediated death: a gene therapy approach. Molecular Therapy 7 2 (2003) 185-192
25. Windbichler G.H., Hausmaninger H., Stummvoll W., Graf A.H., Kainz C., Lahodny J., Denison U., Muller-Holzner E., and Marth C. Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial. British Journal of Cancer 82 6 (2000) 1138-1144
26. Wu J., Xiao X., Zhao P., Xue G., Zhu Y., Zhu X., Zheng L., Zeng Y., and Huang W. Minicircle-IFNgamma induces antiproliferative and antitumoral effects in human nasopharyngeal carcinoma. Clinical Cancer Research 12 15 (2006) 4702-4713
27. Yu X.F., Yang C., Liang L.H., Liu B., Zhou B., Li B., and Han Z.C. Inhibition of human leukemia xenograft in nude mice by adenovirus-mediated tissue inhibitor of metalloproteinase-3. Leukemia 20 1 (2006) 1-8
28. Zhang F., Lu W., and Dong Z. Tumor-infiltrating macrophages are involved in suppressing growth and metastasis of human prostate cancer cells by INF-beta gene therapy in nude mice. Clinical Cancer Research 8 9 (2002) 2942-2951